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Emerging evidence indicates that heterogeneity in ribosome composition can give rise to 
specialized functions. Until now, research mainly focused on differences in core ribosomal 
proteins and associated factors. The impact of posttranslational modifications has not been 
studied systematically. Analyzing ribosome heterogeneity is challenging since individual 
proteins can be part of different subcomplexes (40S, 60S, 80S and polysomes). Here, we 
develop polysome proteome profiling to obtain unbiased proteomic maps across ribosomal 
subcomplexes. Our method combines extensive fractionation by sucrose gradient centrifugation 
with quantitative mass spectrometry. The high resolution of the profiles allows us to assign 
proteins to specific subcomplexes. Phosphoproteomics on the fractions reveals that 
phosphorylation of serine 38 in RPL12/uL11, a known mitotic CDK1 substrate, is strongly 
depleted in polysomes. Follow-up experiments confirm that RPL12/uL11 phosphorylation 
regulates translation of specific subsets of mRNAs during mitosis. Together, our results show 





The ribosome is a large ribonucleoprotein complex which translates mRNAs into proteins and 
thus plays a central role in all living cells (Bashan and Yonath, 2008; Schmeing and 
Ramakrishnan, 2009; Steitz, 2008). The translation efficiency of mRNAs is a key mediator of 
protein abundance and thus gene expression control (Schwanhäusser et al., 2011). It is now 
clear that regulatory elements of mRNAs can modulate every step of protein synthesis from 
initiation to termination (Truitt and Ruggero, 2017). These cis-regulatory elements mediate the 
dynamic interaction of mRNAs with trans-acting factors such as RNA-binding proteins or 
microRNAs (Carpenter et al., 2014). Also, mRNAs can be modified to recruit or repel specific 
binders (Edupuganti et al., 2017; Wang et al., 2015). 
 
Ribosomes themselves are traditionally seen as homogenous molecular machines with little 
regulatory potential. However, the ribosome filter hypothesis proposes that ribosomal subunits 
act themselves as regulatory elements (or “filters”) that mediate interactions with particular 
mRNAs and control their translation (Mauro and Edelman, 2002). Emerging evidence suggests 
that different types of ribosomes exist: Heterogeneity can occur at the level of (i) rRNAs, (ii) core 
ribosomal proteins (RPs), (iii) ribosome-associated proteins and (iv) post-translational 
modifications (PTMs) (reviewed in (Mauro and Matsuda, 2016; Shi and Barna, 2015)). Recent 
examples include the core RPs RPL38/eL38 (Xue et al., 2014), RPL40/eL40 (Lee et al., 2013), 
RPL10A/uL1 and RPS25/eS25 (Shi et al., 2017). These RPs appear to selectively regulate 
translation of distinct subpools of mRNAs (Shi et al., 2017; Xue et al., 2014). Also, LIN28A (Cho 
et al., 2012) and PKM2 (Simsek et al., 2017) are ribosome-associated proteins localized at the 
endoplasmic reticulum (ER) and confer specialized functions to ribosomes translating proteins 
into the ER. Many aspects of ribosome heterogeneity remain poorly understood. In particular, 
the role of PTMs for ribosome function is unclear: While proteomics identified many modification 
sites in RPs (Wilhelm et al., 2014), only few of these modifications have been reported to be 
involved in translational control (Gressner and Wool, 1974; Martin et al., 2014; Spence et al., 
2000). No systematic analysis on the impact of ribosomal PTMs on protein translation has so far 
been reported.  
 
Mass spectrometry (MS)-based quantitative proteomics (Aebersold and Mann, 2016) is a 
powerful technology to systematically study ribosome composition. For example, the Williamson 
lab used quantitative proteomics to study ribosome assembly in E. coli (Chen and Williamson, 
2013; Davis et al., 2016). Proteomic analyses in mammals identified more than 1,500 proteins 
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as the so-called “mammalian riboproteome" (Aviner et al., 2017; Reschke et al., 2013). 
Recently, tagged endogenous RPs were pulled down to identify associated proteins (Simsek et 
al., 2017). These experiments yielded exciting insights. However, it is important to note that the 
same RP is part of several, functionally different ribosome subcomplexes: the small and large 
subunits (that is, 40S and 60S), monosomes (80S) and polysomes. In addition, the small 
subunit also forms 43S and 48S subcomplexes during translation initiation (Sonenberg and 
Hinnebusch, 2009). Affinity purification with tagged RPs cannot distinguish between these 
subcomplexes. Ribosome heterogeneity across different subcomplexes has not yet been 
analyzed systematically. 
 
Here, we developed polysome proteome profiling (3P) -- a method that combines extensive 
sucrose gradient fractionation with accurate quantification -- to systematically characterize 
ribosome composition across subcomplexes. Using this method we obtain proteomic maps of 
translating ribosomes at high resolution. These data allows us to assess the distribution of core 
RPs and ribosome-associated proteins across subcomplexes. Quantitative phosphoproteomics 
in 3P fractions reveals differences in the phosphorylation state of RPs between subcomplexes. 
Intriguingly, follow-up experiments reveal that phosphorylation of RPL12/uL11 on serine 38 






Polysome proteome profiling yields high resolution proteomic maps of translating 
ribosomes 
The gold standard method to resolve different ribosome subcomplexes is sucrose density 
centrifugation (Britten and Roberts, 1960). However, cytosolic fractions generated by this 
method contain many other proteins in addition to ribosomes. Distinguishing specific ribosome 
components from contaminants is a major challenge. Several proteomic techniques use co-
migration to study protein complexes (Kristensen and Foster, 2013). The principle of these 
methods is that lysates are separated into fractions under native conditions (Havugimana et al., 
2012; Heide et al., 2012; Kristensen et al., 2012). Quantitative shotgun proteomics then reveals 
which proteins co-fractionate and are thus part of the same complex. We reasoned that 
combining sucrose density gradient centrifugation and quantitative proteomics should yield high 
resolution maps of cytosolic ribosomes. We refer to this approach as “polysome proteome 
profiling” (3P). It consists of three steps: First, sucrose gradient centrifugation is used to obtain 
many density fractions covering the 40S, 60S and 80S complexes as well as polysomes. 
Second, the protein abundance in all fractions is accurately quantified relative to an internal 
reference standard. Third, the quantitative profiles obtained in this manner are compared to 
ribosome consensus profiles to identify which proteins are indeed ribosome-associated. 
The quality of data obtained depends on the number of fractions and the accuracy of 
quantification. We therefore sampled many fractions along the sucrose gradient and used stable 
isotope labeling by amino acids in cell culture (SILAC) for quantification (Ong et al., 2002) 
(Figure 1A): First, lysates from differentially SILAC labeled cells were individually resolved into 
36 fractions. Next, individual fractions from light and heavy cells were combined as biological 
duplicates. As an internal standard, all fractions from medium-heavy cells were first pooled and 
then spiked into each fraction from the combined light and heavy mixtures. Hence, the ratios of 
light and heavy peptide peaks relative to the medium-heavy internal standard directly reflect 
protein abundance across the sucrose gradient (Figure 1B). Key advantages of this setup are 
the use of an internal standard and the high number of fractions, which yields accurate high 
resolution profiles. 
We analyzed two independent biological replicates of two HEK293 and HeLa cells and identified 
4,030 proteins in total (Table S1). This list contains all known RPs except for RPL41/eL41 and 
RS4Y1/RS4Y2/eS4. RPL41/eL41 has no tryptic peptides of sufficient length and 
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RS4Y1/RS4Y2/eS4 is male-specific and thus not expressed in the two female cell lines used. 
To ensure accurate quantification, we required proteins to be quantified in at least ten fractions, 
which reduced the number of proteins to 1,609. Clustering of ratios revealed high reproducibility 
between biological replicates and cell lines (Figure 1C). Intriguingly, all proteins of the small 
(40S, n=32) and large (60S, n=44) subunit of the ribosome fell into two distinct clusters (Figure 
1B). Hence, if these proteins were not yet known to be ribosomal proteins, our analysis would 
have identified them and assigned them to the correct subunit. Mitochondrial RPs clustered 
separately, even though the large subunit of the mitochondrial ribosome and the small subunit 
of the cytosolic ribosome have very similar sedimentation rates (39S and 40S, respectively). 
Plotting the profiles of all RPs revealed separate peaks for the 40S, 60S and 80S complexes 
that correlated well with RNA profiles obtained from the same samples (Figure 1D). Polysomes 
with two, three, four and more ribosomes per mRNA were also clearly distinguishable. Hence, 
our proteomic profiles are indeed of high resolution and can differentiate between ribosomal 
states. 
 
Composition of the core ribosome 
Core RPs are traditionally thought to have a fixed stoichiometry across different states. A recent 
paper challenged this view and reported that in mouse ES and yeast cells, some RPs appear to 
be more abundant in monosomes than in polysomes and vice versa (Slavov et al., 2015). 
However, this study used only five fractions and lacked an internal standard, limiting its 
resolution and accuracy. In our data, all 76 quantified RPs showed similar abundance profiles 
across monosome and polysome fractions in both HEK293 and HeLa cells. Polysome proteome 
profiles from mouse ES cells confirmed this finding (Figure S1A and B). We conclude that, in 
contrast to the previous report, the composition of the core ribosome does not significantly differ 
between monosomes and polysomes in these cell lines. Importantly, this finding does not 




A study identified ~1.500 proteins in polysome fractions from prostate cancer cells lines as the 
so-called “mammalian riboproteome” (Reschke et al., 2013). We identified 2,327 proteins in 
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polysome fractions of HEK293 and HeLa cells, including many of the previously published ones 
(Figure 2A, upper panel). However, since polysome fractions are crude, not all proteins in these 
lists are ribosome-associated. For example, both our and the published data are enriched in 
mitochondrial RPs (Figure 2A, lower panel). Hence, the so-called “mammalian riboproteome” 
(Reschke et al., 2013) is contaminated by proteins derived from co-sedimenting complexes. 
True polysome-associated proteins should follow the abundance profile of RPs. Therefore, we 
compared the profiles of candidate proteins to a polysome consensus profile obtained by 
averaging over all RPs (Figure S2A) and computed the mean squared deviation (“MSD values”) 
between a given profile and the consensus (Figure 2B) (Andersen et al., 2003; Foster et al., 
2006). MSD values were reproducible between biological duplicates and cell lines (Figure 2C 
inset, Figure S2B). We then used a MSD cut-off to define polysome-associated proteins and 
only kept proteins identified in both biological replicates (Table S1). This eliminated all 
contaminating mitochondrial RPs (Figure 2D). To benchmark our method we created a 
reference set using GO terms, the STRING database (Szklarczyk et al., 2017) and RNAi 
screening data (Badertscher et al., 2015; Wild et al., 2010) (see Methods and Table S2 for the 
reference set). We found that our data captures known ribosome-related proteins with very good 
sensitivity and specificity (Figure 2E). 
We identified 145 polysome-associated proteins (Figures 2F and S3, Table S1 “category 1”). 
Over 70% of these proteins are ribosome-related and/or RNA-binding (Figures 2F and 2G). 
Estimating absolute protein abundance via intensity-based absolute quantification (iBAQ) 
(Schwanhäusser et al., 2011) revealed that polysome-associated proteins were 1-5 orders of 
magnitude less abundant than core RPs, suggesting that they associate with only a subset of 
ribosomes (Figure 2H). We captured several known polysome interacting proteins (Figures 2I) 
such as RACK1 (Thompson et al., 2016), STAU1 (Ricci et al., 2014) and SEC61 (Voorhees et 
al., 2014). The data reveals ribosome association with subunit resolution: For example, RACK1 
and STAU1 have been reported to interact with the 40S and 60S subunits, respectively (Ricci et 
al., 2014; Sengupta et al., 2004), which is reflected in the profiles (Figure 2I). Also, the polyA 
binding protein PABPC4 associated with 80S and polysomes but not with individual subunits. 
Computing MSD values using either 40S or 60S RPs as reference (Figure S2A) allowed us to 
categorize ~46% of our 145 polysome associated proteins as 40S or 60S specific interactors 
(Figures 2J and S2C). 
84 of the 145 polysome interactors have not been described previously. This includes kinases, 
deubiquitinating enzymes and other interesting proteins, highlighting the diversity of ribosome 
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function. We provide individual profiles for all 145 proteins (class I category) and corresponding 
MSD value plots as a supplementary dataset (“polysome_associated_proteins.pdf”). In addition, 
we provide profiles for 40 proteins that passed the cut-offs in only one of the two replicates in 
either cell line (Table S1 “category 2”), including known proteins like LARP4 and UPF1. 4 out of 
5 tested new candidates could be validated (Figure S2D and E).  
  
Phosphorylation of RPs 
Many RPs carry posttranslational modifications (PTMs), but their function is largely enigmatic 
(Simsek and Barna, 2017). For example, while phosphorylation of RPS6/eS6 was identified over 
40 years ago (Gressner and Wool, 1974), its functional relevance is still unclear (Meyuhas, 
2015).	 We reasoned that combining 3P and phosphoproteomics might identify sites with 
regulatory potential. To this end, we used TiO2-based enrichment (Rappsilber et al., 2007) on 
our fractions (Figure 1A). We identified 1,819 class 1 phosphorylation sites (Olsen et al., 2006) 
in 1,143 proteins, including 46 phosphosites in RPs (Figure 3A). To identify sites that might 
regulate ribosome function we compared profiles of all phosphopeptides with the consensus 
profiles (Figure 3B). Most phosphopeptide profiles resembled the consensus profiles, including 
the key phosphorylation sites in RPS6/eS6 (Figure 3C). This is interesting since S6 
phosphorylation was originally thought to regulate translation. Our data corroborates genetic 
studies showing that S6 phosphorylation is dispensable for polysome association (Ruvinsky et 
al., 2005). 
Of all phosphosites covered, pS38 in RPL12/uL11 deviated most from the consensus profile 
(Figure 3B and 3D): pS38 levels were high in 60S and 80S fractions but low in polysome 
fractions. To validate this finding, we generated stable HEK293 cell lines expressing FLAG/HA-
tagged wild-type (WT) RPL12/uL11, a phosphomimetic S38D mutant or a non-phosphorylatable 
S38A mutant. Sucrose gradient fractionation showed that tagged WT RPL12/uL11 is 
incorporated into ribosomes and behaves similarly to the endogenous protein (Figure 3E, see 
Figure S3A for different clones). The S38D mutant was strongly depleted in polysomes, 
corroborating the proteomic data. Of note, the mutant was incorporated into ribosomes, 
suggesting that dephosphorylation is not needed for ribosome assembly. The S38A mutant 
behaved similarly to the wild-type, indicating that RPL12/uL11 phosphorylation is not required 
for ribosome assembly nor translation initiation. We conclude RPL12/uL11 S38 phosphorylation 




RPL12/uL11 S38 is an evolutionarily conserved mitotic CDK1 substrate 
The sequence surrounding S38 is highly conserved in eukaryotes and matches a consensus 
motif for CDK1 substrates (pS-P-K-K) (Figure 4A). Phosphorylation of RPL12/uL11 on S38 has 
been observed in several species (Gnad et al., 2011). Phosphoproteomic data across the cell 
cycle in HeLa cells revealed that RPL12/uL11 S38 phosphorylation peaks in mitosis and 
reaches the lowest level in S phase (Figure 4B) (Dephoure et al., 2008; Olsen et al., 2010). 
Consistently, CDK1/2 phosphorylates RPL12/uL11 in vitro (Chi et al., 2008). Also, the CDK1-
cyclin B complex physically associates with RPL12/uL11 during mitosis in HeLa cells (Pagliuca 
et al., 2011). Finally, experiments with an analog sensitive CDK1 variants indicate that CDK1 
directly phosphorylates RPL12/uL11 on S38 during mitosis in yeast (Holt et al., 2009). Thus, 
RPL12/uL11 S38 is an evolutionarily conserved mitotic CDK1 substrate. Similar to other CDK1 
substrates, the occupancy of S38 phosphorylation in mitosis is as high as ~70% (Olsen et al., 
2010). 
 
RPL12/uL11 S38 phosphorylation does not globally affect translation 
RPL12/uL11 is located close to the A-site in the P stalk of the ribosome -- a site where multiple 
ribosomal GTPases such as an elongation factor eEF1A and a termination factor eRF1 bind (Liu 
et al., 2015; Spahn et al., 2004; Taylor et al., 2012) (Figure 3A). Since knockdown of 
RPL12/uL11 attenuates translation elongation in human and yeast cells (Briones et al., 1998; 
Veit et al., 2016) we hypothesized that phosphorylation might globally affect translation during 
mitosis. Early experiments suggested that translation is globally suppressed in mitosis (Fan and 
Penman, 1970; Wilker et al., 2007). However, this suppression might be an artifact caused by 
the drugs employed (Coldwell et al., 2013; Shuda et al., 2015). To measure protein synthesis 
without drug treatment we used metabolic pulse labeling in a flow cytometric assay (Kiick et al., 
2001; Shuda et al., 2015) (Figure 4C). HEK293 cells transiently expressing FLAG/HA tagged 
RPL12/uL11 WT, S38D or S38A were pulse-labeled with azidohomoalanine (AHA) to measure 
global protein synthesis (Figure 4D left panel). Histone H3 pS10 was used as a mitotic marker 
(Figure 4C). We found no significant difference in global protein synthesis between the 
RPL12/uL11 variants -- neither in interphase nor in mitosis (Figure 4D right panel). All we 
observed was a slight reduction in the fraction of mitotic cells in both mutants (Figure 4E). We 




RPL12/uL11 S38 phosphorylation regulates translation of mitosis-related mRNAs 
We next asked whether RPL12/uL11 phosphorylation might regulate translation of specific 
subsets of mRNAs. To quantify differences in protein production between the D and the A 
mutant we used pSILAC (Schwanhäusser et al., 2009) (Figure 5A left panel; Table S3). We then 
selected a subset of proteins that had been reported to be preferentially translated in mitosis 
according to ribosome profiling data (Stumpf et al., 2013). Translation of this subset was 
significantly higher in cells with S38D ribosomes, consistent with our hypothesis (Figure 5A, 
right). Conversely, S38A cells preferentially translated mRNAs that are more actively translated 
in S phase. Hence, phosphorylation of S38 appears to regulate translation of specific mRNAs. 
Interpretation of the pSILAC data is complicated by the fact the cells express both tagged and 
endogenous (that is, wild-type) RPL12/uL11. We next sought to analyze only ribosomes 
containing the tagged variants (Figure 5B, left panel). We isolated monosomes by sucrose 
gradient centrifugation from HEK293 cells expressing tagged RPL12/uL11 WT, S38D or S38A. 
These monosome fractions contain both ribosomes with endogenous RPL12/uL11 and with 
tagged RPL12/uL11 variants. We then used an anti-FLAG antibody to immunoprecipitate 
ribosomes with tagged RPL12/uL11 from monosome fractions (Figure S3B). Both the 
precipitated ribosomes and the corresponding monosome fractions were analyzed by RNA-seq. 
Hence, every immunoprecipitated sample is accompanied by its own internal control (i.e. the 
corresponding whole monosome fraction). We classified mRNAs according to their enrichment 
ratios (IP vs monosome fraction) for different combinations of RPL12/uL11 variants (Figure 
S3C; Table S4). The differences in mRNAs enrichment between S38D and S38A were small. 
However, several well-known mitotic factors such as cohesins (SMC3, SMC1B), mitotic spindle 
proteins (DLGAP5, KIF11, TPX2), kinetochore components (CENP-C) and mitotic cyclins B1 
and B2 (CCNB1, CCNB2) were in the high enrichment group (log2 D/A, Table S4). Gene 
ontology analysis of transcripts associated with the phosphomimetic mutant revealed 
enrichment of terms related to the cell cycle (“cell cycle”, “regulation of cell cycle”) and 
posttranscriptional regulation (“translation”, “RNA processing”, “ribosomal large subunit 
biogenesis”) (Fig. 5 C). 
To globally assess mitosis-specific translation, we calculated the ratios of ribosome protected 
fragments during mitosis and S phase in ribosome profiling data (Stumpf et al., 2013) for the 
different subgroups. We found that monosomes containing S38D preferentially associated with 
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mRNAs with higher mitosis-specific ribosome occupancy than monosomes with S38A (Figure 
5B, right panel). Comparing S38D to wild-type RPL12/uL11 revealed the same trend (Figure 
S3D upper panel). In contrast, S38A ribosomes and wild-type monosomes did not show 
significant differences (Figure S3D bottom panel). This validates the pSILAC data and confirms 
the hypothesis that RPL12/uL11 phosphorylation shifts the ribosomal translation profile towards 
mitosis. 
We next wanted to identify mRNA sequence features correlated to preferential binding to the D 
or A mutant. Genes in the category “M phase of the mitotic cell cycle” have been reported to 
display a characteristic codon usage pattern, typically with A or U in the last codon (that is, 
“wobble”) position (Gingold et al., 2014). Therefore, we followed a strategy similar to (Presnyak 
et al., 2015) to assess if codon frequencies correlate with observed differences in enrichment 
values between the D and the A mutant. Strikingly, the 10 codons with the strongest positive 
and negative correlation all showed a A/U or G/C at the third position, respectively (Fig. 5D). 
Hence, mRNAs associated with the phosphomimetic mutant and mRNAs encoding proteins with 
a function in mitosis show the same A/U preference in the wobble position. The same trend is 
also seen in the total AU content (Fig. 5E). 
In addition to translation itself, protein production can be affected by changes in mRNA levels. 
While mitotic chromatin was previously thought to be transcriptionally silent, a recent study 
found that many mRNAs are synthesized during mitosis (Palozola et al., 2017). Integrating 
these data with ours revealed that mitotically transcribed mRNAs preferentially associate with 
ribosomes carrying the D mutant, providing another link between RPL12/uL11 phosphorylation 
and mitosis (Fig. 5F). When we only consider mRNAs that are strongly transcriptionally induced 
during mitosis, the difference between the D and A mutant is less pronounced. It thus appears 
that protein production in mitosis is controlled by at least two mechanisms acting on different 
sets of genes: One is up-regulated transcriptionally while the other is continuously transcribed 
and regulated via RPL12/uL11 phosphorylation at the level of the ribosome. The mRNAs in 
these two subsets can be distinguished by their G/C content, consistent with the observed 
codon bias (Fig. 5G). 
 




To further validate our findings we used CRISPR to mutate the endogenous RPL12/uL11 gene 
in mouse B lymphoma cells (19DN) (Sander et al., 2015). We obtained both a homozygous 
RPL12/uL11 S38D and a S38A cell line (Figure S4A and B). Repeating the above-mentioned 
experiments with these cells confirmed the key findings from HEK293 cells: First, wild-type, 
S38D and S38A mutant cells synthesize similar amounts of protein (Figure 6A left panel). 
Second, we observed a slight reduction in the fraction of mitotic cells in both mutants (Figure 6A 
right panel). Third, the S38D mutant preferentially translates mitosis-related transcripts (Figure 
6B and Figure S5A). To validated these we randomly selected 50 proteins with absolute log2 
FCs > 0.1 in the pSILAC data and designed parallel reaction monitoring (PRM) assays for them 
using Picky (Zauber et al., 2018) (see Methods). This confirmed differential regulation for 34 of 
the 41 identified proteins (Figure S5B). These data indicate that the regulatory function of 
RPL12/uL11 phosphorylation is conserved and partially cell type independent. 
Having a model system in which the entire pool of endogenous RPL12/uL11 is replaced by the 
phosphomimetic or non-phosphorylatable mutant allows us to use ribosome profiling as an 
additional read-out for translation (Ingolia, 2016). We performed ribosome profiling in S38D and 
S38A B cells. Ribosome protected fragment (RPFs) showed the characteristic periodicity that 
indicates genuine translation (Figure S5C-E). Proteins that are differentially translated according 
to our pSILAC data also showed highly significant differences in RPFs between the D and the A 
mutant in the ribosome profiling data (Fig. 6C and Figure S5F). Hence, two independent read-
outs provide consistent results. To define our own subset of mitotically translated mRNAs we 
also performed ribosome profiling on mitotic wild-type cells (Figure S5G, S5H). Comparing 
RPFs in mitotic and asynchronous wild-type cells allowed us to define a set of 692 mRNAs that 
are preferentially translated in mitosis and 792 mRNAs which are more translated in 
asynchronous cells. The mitotic subset is functionally linked to translation and RNA processing 
(Figure S5I), consistent with a previous report in human cells (Park et al., 2016). We then 
compared the translation of these subsets in the D and the A mutant. Again, we observed that 
cells expressing phosphomimetic RPL12/uL11 exhibited higher RPFs for the mitotic subset than 
cells expressing the non-phosphorylatable mutant (Figure 6D and Table S6). Altogether, results 
from three independent experimental approaches (pSILAC, RNA-seq of affinity purified 
monosomes, ribosome profiling) and two different model systems (human HEK cells, mouse B 





The polysome proteome profiling (3P) approach presented here provides proteomic maps of 
translating ribosomes. The high resolution of these maps allows us to unambiguously assess 
the composition of different subcomplexes -- a key advantage over conventional affinity 
purification approaches (Simsek et al., 2017). The method does not involve tagging or 
overexpression and can thus be readily applied to different tissues or model organisms. Despite 
these advantages, it is also important to keep the limitations of the method in mind. First, high 
resolution profiles requires analysis of many fractions and thus long measurement times. 
Second, 3P (and classical affinity purification) involves cell lysis, which might result in loss of 
weak interactions or artifactual binding in lysates. Third, since individual fractions contain 
thousands of ribosomes, the data represents the average for many complexes in every density 
range. For example, while ribosomes with different core RP composition have been reported to 
exist (Ferretti et al., 2017; Shi et al., 2017), this heterogeneity at the level of single ribosomes 
cannot be resolved by 3P. In fact, our absolute abundance estimates indicate that several core 
RPs are sub-stoichiometric, supporting the view that the composition of individual ribosomes 
can indeed differ (Figure 2H). 
 
Our data indicates that the core RP composition does not significantly differ between 
monosomes and polysomes (Figure 1D), in contrast to a previous report (Slavov et al., 2015). 
Also, while a previous study reported over 1,000 ribosome-associated proteins (Reschke et al., 
2013), our rigorous profiling indicates that most of them are contaminants (Figures 2A and 2D). 
We identify a high confidence set of 145 polysome associated proteins with a wide range of 
biological functions (Figure 2F). Finally, our phosphoproteomic analysis identifies S38 in 
RPL12/uL11 as phosphorylation site that regulates translation during mitosis. 
 
Translation is traditionally thought to be globally suppressed during mitosis (Fan and Penman, 
1970), but more recent data challenges this view (Aviner et al., 2013; Park et al., 2016; Stumpf 
et al., 2013; Tanenbaum et al., 2015). Several cis-regulatory elements in mRNAs such as 
internal ribosome entry sites (IRESs), 5' terminal oligopyrimidine tracts (TOPs), 5’ caps and 
poly(A) tail length have been reported to control mitotic translation (Park et al., 2016; Shuda et 
al., 2015; Wilker et al., 2007). Splicing factors bind polysomes in mitosis and affect translation of 
specific messages (Aviner et al., 2017). Modifications of the ribosome itself has not yet been 
reported to regulate translation in a cell cycle dependent-manner. We studied the impact of 
	
14	
RPL12/uL11 phosphorylation on translation using phosphomimetic and non-phosphorylatable 
mutants. Based on these experiments we arrived at three conclusions. First, phosphorylation 
does not have a major impact on total protein synthesis (Figure 4). Second, RPL12/uL11 
phosphorylation shifts protein production of ribosomes towards a more mitotic translation profile 
(Figure 5A). Third, ribosomes with phosphorylated RPL12/uL11 associate with mRNAs that are 
more actively translated during mitosis (Figure 5B). An important caveat in these experiments is 
that the phosphomimetic (or non-phosphorylatable) mutant may behave differently than 
endogenous phosphorylated (or non-phosphorylated) RPL12/uL11. However, we observed that 
the sucrose gradient profiles of the mutants resembled the profiles of phosphorylated and non-
phosphorylated RPL12/uL11 (Figures 3E and S4A). Thus, the mutants appear to reflect key 
aspects of RPL12/uL11 phosphorylation. 
 
It is remarkable that HEK 293 cells overexpressing phosphomimetic and non-phosphorylatable 
RPL12/uL11 variants and the corresponding mutant B cell lines do not show more dramatic 
phenotypes. This might be due to three (not mutually exclusive) reasons. First, the observed 
differences between the variants are quite small, suggesting that phosphorylation modulates 
rather than switches ribosome function. Second, the eukaryotic cell cycle is robustly designed 
and comprises multiple redundant components and feedbacks (Li et al., 2004; Zhu and Mao, 
2015). Therefore, cell perturbations can be tolerated, as for example seen in the remarkably 
subtle phenotypes of Cdk2 and cyclin E knock-out mice (Geng et al., 2003; Ortega et al., 2003). 
Third, loss of function mutations in individual RP coding genes often have cell type specific and 
sometimes subtle phenotypes (Mauro and Matsuda, 2016; Shi and Barna, 2015). Interestingly, 
the profile of the S38D RPL12/uL11 in B cells follows the 60S consensus profile without 
depletion in polysomes (Figure S4C and D). Whether this reflects compensatory mechanisms is 
not clear. More generally, the relationship between polysome depletion of phosphorylated 
RPL12/uL11 and mitotic translation remains to be investigated. While actively translated 
mRNAs are believed to be limited to polysomes, a recent study showed that also monosomes 
contribute to translation of mRNAs such as short open reading frames (ORFs) and long ORFs 
with slow initiation rates that encode regulatory proteins (Heyer and Moore, 2016). In this 
context, it is important to note that ribosomes with phosphomimetic and non-phosphorylatable 
RPL12/uL11 interact with different mRNAs even when both are purified from monosome 
fractions (Figure 5B). Thus, selective mRNA binding is already seen in monosomes and does 




How does RPL12/uL11 phosphorylation regulate translation? RPL12/uL11 is located in the 
ribosomal GTPase associated center (GAC) to which translational GTPases access in order to 
stimulate their hydrolytic activity during protein synthesis. RPL12/uL11 regulates elongation 
through interaction with two elongation GTPases,  eEF1A and eEF2 (Briones et al., 1998; Veit 
et al., 2016; Wawiórka et al., 2016), which drive aminoacyl-tRNA decoding and translocation of 
the new peptidyl-tRNA during elongation, respectively. The phosphorylation site is proximal to 
the binding site for eEF1A (Liu et al., 2015) and eEF2 (Anger et al., 2013). It is tempting to 
speculate that phosphorylated RPL12/uL11 modulates binding affinity towards specific tRNAs, 
thereby facilitating elongation of specific mRNAs (Presnyak et al., 2015). In this context, the 
observed codon/GC content bias is noteworthy (Figure 5E). While the functional relevance of 
this observation is unclear, it is interesting that both mRNAs associated with the D mutant 
(Figure 5D) and mRNAs that are functionally related to mitosis (Gingold et al., 2014) are AU-
rich. Since RPL12/uL11 depletion causes initiation delay, phosphorylation may 
alternatively/additionally regulate the initiation step (Wawiórka et al., 2016). 
 
In summary, our proteomic picture of ribosome heterogeneity reveals that RPL12/uL11 
phosphorylation regulates mitotic translation. This further supports the ribosome filter hypothesis 
(Mauro and Edelman, 2002) and extends the recent finding that heterogeneous ribosomes 
preferentially translate distinct subpools of mRNAs (Shi et al., 2017). To our knowledge, this is 
the first study demonstrating that posttranslational modifications of RPs can affect translation. 
Since many RPs can be modified by many types of PTMs, other examples may soon emerge. 
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Main figure titles and legends 
Figure 1. Polysome proteome profiling (3P) 
(A) Experimental design for 3P. (B) Exemplary spectra for two peptides across fractions, one for 
a small (RPS25/eS25) and one for a large (RPL8/uL2) subunit protein. Fraction numbers are 
like in panel D. (C) Hierarchical clustering for 1,609 proteins quantified in more than 10 fractions 
in at least one cell line. Columns refer to density gradient fractions (from fraction 1 to 36). Rows 
represent individual proteins. (D) Abundance profiles for individual ribosomal proteins across 
density gradient (shown for HEK293 replicate 2 as an example). The corresponding UV 
absorbance profile at 254 nm (dominated by ribosomal RNA) is shown in the top right corner of 
the figure.	
	
Figure 2. Mapping polysome interacting proteins 
(A) Top: Overlap of proteins (excluding ribosomal proteins) identified in polysome fractions in 
our study and the so-called “mammalian riboproteome”. Bottom: Complexes with cytosolic RPs 
(green bars, including ribosomal proteins) and several non-ribosomal complexes (purple bars) 
are significantly enriched. (B) To identify ribosome-associated proteins profiles of individual 
proteins are compared to the polysome consensus profile by computing MSD values. (C) 
Observed distribution of MSD values in HEK293 (green). Cytosolic (red) and mitochondrial RPs 
(purple) can be easily separated. The MSD value distribution of  an exemplarily shuffled dataset 
is depicted in grey. Multiple shuffling operations were used to define cut-offs (nominal FDR=0). 
Insets show reproducibility of MSD values between replicates. (D) Same as in (A) but only using 
proteins that pass the MSD cut-off (i.e. polysome-associated proteins). (E) Receiver-operator 
characteristic (ROC) curves for our data compared to a reference dataset. Red and green ROC 
curves depict polysome interactomes with and without cytosolic RPs, respectively. (F) Top: 
Overlap of polysome-associated proteins in HEK293 and HeLa. Bottom: Enriched GO terms 
among the 145 polysome associated proteins (adjusted P<0.01). (G) Fractions of proteins with 
ribosome-related annotations for different subsets. (H) Absolute abundance estimates of 
cytosolic RPs and polysome-associated proteins. (I) Abundance profiles for three known 
polysome interactors. (J) Scatter plot of MSD values calculated from 40S fractions (x-axis) and 
60S fractions (y-axis) in HEK293 (see Figure S3C for HeLa). Fractions of 40S-associated, 60S-
associated and unassigned proteins are shown in the top right corner.	
	
Figure 3. Phosphorylation profile of RPs 
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(A) Quantified phosphorylation sites of RPs mapped to the ribosome structure (PDB: 4V6X; 
(Anger et al., 2013). Phosphorylated RPSs and RPLs are shown in blue and red, respectively. 
An enlarged view of the P stalk shows that RPL12/uL11 pS38 is proximal to the ribosomal 
GTPase EEF2. (B) MSD values of phosphosites indicate that phosphorylation of most sites 
does not significantly vary across complexes. RPL12/uL11 pS38 (red) shows the largest 
divergence from consensus profiles. (C) Profile for RPS6/eS6 in HeLa cells. Blue and red lines 
indicate consensus profiles of 40S and 60S proteins, respectively. Abundance of RPS6/eS6-
derived phosphopeptides are shown as gray bars. (D) Profiles for RPL12/uL11 pS38 in HeLa 
(left). Representative MS spectra from fractions 9-10 and 31-32 (second panel), a 
representative MS/MS spectrum of RPL12/uL11 pS38 (third panel) and profiles for RPL12/uL11 
pS38 in HEK293 (right panel) are also shown. (E) Western blots of whole cell lysates from 
HEK293 cells stably expressing FLAG/HA-tagged RPL12/uL11_WT,  S38D or S38A. 
 
Figure 4. Impact of RPL12/uL11 pS38 on global protein synthesis 
(A) Conservation and phosphorylation motif of RPL12/uL11 S38. (B) Phosphorylation of S38 
during the cell cycle in published phosphoproteomic data. (C) Experimental design for flow 
cytometric analysis of mitotic translation in HEK293 cells transiently expressing FLAG/HA 
tagged RPL12/uL11. (D) Monitoring global protein synthesis in interphase and mitotis. Left: 
Representative FACS result of cells expressing FLAG/HA RPL12/uL11 WT. Only cells 
expressing tagged RPL12/uL11 were gated and the corresponding cell population was further 
analyzed by dual staining for phospho H3 S10 and AHA-labeled proteins. Global protein 
synthesis was monitored by AHA incorporation (y-axis) in interphase and mitosis (based on H3 
pS10 staining, x-axis). Right: Each dot represents median AHA intensity calculated from 
interphase or mitotic cell population in an independent experiment. The results from three 
independent experiments are shown. As controls, methionine (Met) incorporation into proteins 
instead of AHA and protein production in the presence of CHX were also monitored.  (E) Mitotic 
index determined by flow cytometric analysis of H3 pS10-positive cells expressing tagged 
RPL12/uL11. Data are represented as mean ± SD. P-values were calculated using paired 
student's t test. 
 
Figure 5. Role for RPL12/uL11 pS38 in mitotic translation 
(A) pSILAC quantifies differences in protein production between RPL12/uL11 S38D- and S38A-
expressing cells. Left: Experimental design. Right: Cumulative distribution of log2-fold changes 
(H/M ratios) of protein synthesis. Subsets of proteins whose mRNAs exhibited higher (>2-fold) 
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or lower (<0.5-fold) ribosome occupancy in mitosis than in S phase (Stumpf et al., 2013) is 
shown in light red and light green, respectively. All quantified proteins are shown in gray. P-
values were computed using one-sided Wilcoxon-rank sum tests. (B) RNA-seq analysis of 
monosome-bound mRNAs. Left: Monosomes were isolated by sucrose density gradient 
centrifugation from HEK293 cells stably expressing FLAG/HA RPL12/uL11, followed by anti-
FLAG immunoprecipitation to enrich for tagged RPL12/uL11-containing ribosomes. Poly(A)+ 
RNAs from the monosome fraction (input) and anti-FLAG immunoprecipitated fraction (IP) were 
quantified by RNA-seq. Only mRNAs that exhibited positive enrichment values (IP/input > 0) 
were used for further analysis (see Figure S3C). Right: Cumulative distribution of log2 fold-
changes in ribosome occupancy (mitosis vs S phase, taken from Stumpf et al) for 3 classes of 
mRNAs with high, medium and low enrichment ratios (S38D vs S38A). P-values were computed 
using one-sided Wilcoxon-rank sum tests. (C) GO enrichment analysis for genes that showed 
high S38D/S38A enrichment in the RNA-seq experiment (see Figure 5B). Adjusted p-values by 
Benjamini–Hochberg are shown. (D) Barplots showing correlation coefficient between codon 
frequencies within coding sequences and the observed differences in enrichment ratios 
(S38D/S38A) for all 64 possible triplets. Light red and light blue indicate codons ending in A/U 
and G/C, respectively. (E) Correlation between GC content within coding sequences and the 
observed differences in enrichment ratios(S38D/S38A). (F) Mitotically transcribed mRNAs 
preferentially associate with monosomes carrying the S38D mutant. Boxplots showing changes 
in enrichment ratios (S38D/S38A) for three subsets, "transcribed in mitosis (pink)", 
"transcriptionally induced in mitosis (light blue)" and "other (orange)", based on the dataset from 
(Palozola et al., 2017). P-values were computed using Mann-Whitney U test. (G) Density plots 
of GC contents for the three subsets based on (Palozola et al., 2017). 
 
Figure 6. Translational regulation through RPL12 pS38 in mouse B cells 
(A) Monitoring global protein synthesis in interphase and mitotic cells. Left: Each dot represents 
median AHA intensity calculated from interphase or mitotic cell population in an independent 
experiment. The results from three independent experiments are shown. As a negative control, 
methionine (Met) incorporation into proteins was also monitored instead of AHA. Right: Mitotic 
index determined by flow cytometric analysis of H3 pS10-positive cells. Data are represented as 
mean ± SD. P-values were calculated using paired Student's t test. (B) A pSILAC approach to 
assess the difference in protein production between the S38D and the S38A mutant cells. 
Cumulative distribution of log2-fold changes (H/M ratios) of protein synthesis in asynchronous 
cells is shown (see also Figure S6A for the label-swap experiment). Subsets of proteins whose 
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mRNAs exhibited higher (>2-fold) or lower (<0.5-fold) ribosome occupancy in mitosis than in S 
phase (Stumpf et al., 2013) are shown in light red and light green, respectively. Subsets of 
proteins that exhibited higher (>1.4-fold) or lower (<0.7-fold) ibosome protected fragments 
(RPFs) in mitotic versus asynchronous B cells (our ribosome profiling data, see also Figure S6) 
are shown in red and dark green, respectively. All quantified proteins are shown in gray. P-
values were computed using one-sided Wilcoxon-rank sum tests. (C) Boxplots comparing 
pSILAC (Figure 6B) and ribosome profiling (Figure 6D) for the subsets based on log2 fold-
changes (S38D/S38A) of the pSILAC data. Changes in RPFs were calculated from our own 
Ribo-seq libraries. P-values were computed using one-sided Wilcoxon-rank sum tests. (D) 
Cumulative distribution of log2-fold changes (S38A/S38D) in RPFs in asynchronous cells. 
Subsets are based on our ribosome profiling data (see legend to panel B above). P-values were 
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○ NanoLC-MS/MS Analysis 
○ Parallel Reaction Monitoring (PRM) assay 
○ Processing of Mass Spectrometry Data 
○ Data Analysis of PRM Measurements 
○ Estimation of Protein Abundance Using iBAQ 
○ Generation of HEK293 Stable Cell Lines Expressing FLAG/HA-RPL12 
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KEY RESOURCES TABLE  





Rabbit polyclonal anti-HA Santa Cruz Cat# sc-805 RRID:AB_631618 
Rabbit polyclonal anti-RPL12 Thermo Fisher Scientific Cat#PA5-31670 RRID:AB_2549143 
Rabbit monoclonal anti-RPL12 
(Center) 
Abgent Cat# WA-AP16275c 
RRID:AB_11135986 
Rabbit polyclonal anti-RPS5 Bethyl Laboratories Cat#A304-011A RRID:AB_2620359  
Rabbit polyclonal anti-NUFIP2/82-
FIP antibody 
Bethyl Laboratories Cat# A301-600A  
RRID:AB_1078870 
Rabbit polyclonal anti-GPATCH4 
antibody 
Bethyl Laboratories Cat# A303-405A  
RRID:AB_10954002 
Rabbit polyclonal anti-LLPH 
antibody 
Sigma-Aldrich Cat# SAB1302290 
Rabbit polyclonal anti-UQCRC2 
antibody 
GeneTex Cat# GTX114873  
RRID:AB_11164243 
Rabbit polyclonal anti-H1FX 
antibody 
Aviva Cat# ASB-OAAB10031 
Rabbit polyclonal anti-C11orf48 
antibody 
Origene Cat# TA331749 
Rabbit polyclonal anti-C7orf50 
antibody 
Proteintech Cat# 20797-1-AP  
RRID:AB_10732839 
Rabbit monoclonal phospho-Histone 
H3 (Ser10) (D2C8) (Alexa Fluor 647 
conjugate) antibody 
Cell Signaling Technology  Cat# 3458S RRID:AB_10694086 
Monoclonal anti-DYKDDDK-Biotin Miltenyi Biotec Cat# 130-101-569 
Mouse monoclonal anti-FLAG (M2) Sigma-Aldrich Cat# F3165 RRID:AB_259529 
Rat monoclonal PE/Cy7 Streptavidin Biolegend Cat# BLD-405206 
Sheep anti-mouse IgG-HRP Sigma-Aldrich Cat# NA931 RRID:AB_772210 
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Donkey anti-rabbit IgG-HRP Sigma-Aldrich Cat# NA934 RRID:AB_772206 
Chemicals, Peptides, and 
Recombinant Proteins 
 
Cycloheximide  Sigma-Aldrich  Cat#C4859; CAS: 66-81-9 
nocodazole Sigma-Aldrich Cat#M1404; CAS: 31430-18-9 
L-Azidohomoalanine (AHA)  Anaspec  Cat#AS-63699 
L-Lysine 4,4,5,5-D4 (Lys4)  Cambridge Isotope Laboratories  Cat#DLM-2640 
L-Lysine 13C6 15N2 (Lys8)  Cambridge Isotope Laboratories  Cat#CNLM-291-H 
L-Arginine 13C6 (Arg6)  Sigma-Aldrich  Cat#643440 
L-Arginine 13C615N4 (Arg10)  Sigma-Aldrich  Cat#608033 
Alexa Fluor 488 alkyne Thermo Fisher Scientific Cat#A10267 
Trizol Thermo Fisher Scientific Cat#15596026 
Trizol LS Thermo Fisher Scientific Cat#10296028 
ERCC Spike-in Control Mix 1  Thermo Fisher Scientific Cat#4456740 
TurboDNase Thermo Fisher Scientific Cat#AM2239 
RNase I Thermo Fisher Scientific Cat#AM2295 
SUPERaseIn Thermo Fisher Scientific Cat#AM2696 
Critical Commercial Assays  
Truseq stranded mRNA kit  Illumina Cat#20020594 
RNA Clean and Concentrator kit Zymo Research Cat#R1013 
RiboZero Kit  Illumina Cat#MRZH11124 
QuantSeq 3’ mRNA-Seq Library 
Prep Kit FWD  
Lexogen Cat#SKU: 015.24. 
Deposited Data  
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Proteomic datasets This paper Polysome (phospho)proteome 
profiling for HEK293 and HeLa 
ProteomeXchange: PXD009292;  
 




pSILAC in HEK293 
ProteomeXchange: PXD009307; 
 




pSILAC in B cells 
ProteomeXchange: PXD009276;  
 
PRM assay in B cells 
ProteomeXchange: PXD010029 
RNA-seq and ribo-seq datasets This paper GEO: GSE112187 
Human UniprotKB/Swiss-Prot data 
base (Human UniProt 2014-10) 
N/A http://www.uniprot.org/proteomes/ 
Mouse UniprotKB/Swiss-Prot data 
base (Mouse UniProt 2014-10) 
N/A http://www.uniprot.org/proteomes/ 
Riboproteome data (Reschke et al., 2013) N/A 
Ribosome profiling data (mitosis vs 
S phase) 
(Stumpf et al., 2013) N/A 
Protein complex annotation data 
(CORUM downloaded Jan/2017) 
 




STRING protein interaction 
database  
(Szklarczyk et al., 2017) https://string-db.org/ 
RNAi data for ribosome biogenesis 
proteins 





Experimental Models: Cell Lines  
Human HeLa cells ATCC N/A 
Human HEK293 cells ATCC CRL-1573 
NIH 3T3 mouse fibroblast cells ATCC N/A 
Mouse embryonic stem cells (E14) Michel Vermeulen (Radboud 
Institute for Molecular Life Sciences 
N/A 
Flp-In T-REx 293 Cell Line Thermo Fisher Scientific R78007 
19DN mouse B cells and RPL12 
mutant cells 
(Sander et al., 2012) and this paper N/A 
Oligonucleotides  
oligonucleotides used for genome 
editing, see “Generation of RPL12 
Point Mutant Cell Lines via 
CRISPR/Cas9” 
This paper N/A 
Recombinant DNA  
pDONR221 Thermo Fisher Scientific 
Cat#12536017 
pDEST26_FLAG/HA This paper N/A 
pcDNA5-FLAG/HA-RPL12-WT This paper N/A 
pcDNA5-FLAG/HA-RPL12-S38D This paper 
 
N/A 
pcDNA5-FLAG/HA-RPL12-S38A This paper N/A 
pFRT/TO/FLAG/HA-DEST Thomas Tuschl Addgene ID: 26360 
pX330-Cas9-RPL12sgRNA This paper N/A 
pX330-E2A-mCherry (Chu et al., 2015) N/A 
Software and Algorithms  
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R studio version 1.1.4 N/A https://www.rstudio.com 
MaxQuant v1.5.1.2 (Cox and Mann, 2008) http://www.biochem.mpg.de/511179
5/maxquant 
Metascape (Tripathi et al., 2015) http://metascape.org/ 
Bcl2Fastq (v2.16.0.10) Illumina https://support.illumina.com/sequen
cing/sequencing_software/bcl2fastq-
conversion-software.htmL 
Flexbar (v2.5)  (Roehr et al., 2017) https://github.com/seqan/flexbar/wiki 
collapse_reads.pl script  (Jens, 2016) https://github.com/marvin-
jens/clip_analysis 
STAR aligner v2.4.2a, v2.5.3a (Dobin et al., 2012) https://github.com/alexdobin/STAR 
DESeq2 (v1.18.1) (Love et al., 2014) https://bioconductor.org/packages/re
lease/bioc/htmL/DESeq2.htmL 
FASTX Toolkit (v0.0.14) N/A http://hannonlab.cshl.edu/fastx_tool
kit/ 
Bowtie 2 (v2.3.2) (Langmead and Salzberg, 2012) http://bowtie-
bio.sourceforge.net/bowtie2/index.s
htmL 
HTSeq-count (v0.9.1) (Anders et al., 2014) http://htseq.readthedocs.io/en/maste
r/count.htmL 
Detection of differential translation 
genes (DTGs) using DESeq2 
interaction term 
(Chothani et al., 2017) https://github.com/SGDDNB/DTG-
detection/blob/master/getDTG.md 
cutadapt (v.1.12) (Martin, 2011) http://cutadapt.readthedocs.io/en/sta
ble/guide.htmL 
riboWaltz (v.0.1.0) (Lauria et al., 2017) https://github.com/LabTranslational
Architectomics/riboWaltz 





Titansphere GL Sciences Cat#5010-21315 
MonoCap C18 High Resolution 
2000  
GL Sciences Cat#5020-10015 
Dynabeads Protein G Thermo Fisher Scientific Cat#10004D 
MicroSpin S-400 HR Columns GE Healthcare  Cat#27-5140-01  
 
CONTACT FOR REAGENT AND RESOURCE SHARING  
Further information and requests for reagents may be directed to, and will be fulfilled by the 
corresponding authors, Koshi Imami (imami.koshi.3z@kyoto-u.ac.jp) or Matthias Selbach 
(matthias.selbach@mdc-berlin.de). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Cell Lines 
HEK293, HeLa and NIH3T3 cells (American Type Culture Collection) were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) (life technologies) complemented with glutamax 
(life technologies) and 10% fetal bovine serum (FBS) (PAN-Biotech). For SILAC labeling, cells 
were grown in arginine- and lysine-free DMEM (life technologies) containing 10% (v/v) dialyzed 
FBS (Pan-Biotech), 1% glutamax (life technologies), 1% sodium pyruvate (life technologies) in 
the presence of either 0.2 mM L-arginine (Sigma-Aldrich) and 0.8 mM L-lysine (“light” form) 
(Sigma-Aldrich), L-[13C6]-arginine (Sigma-Aldrich) and L-[2H4]-lysine (“medium-heavy” form) 
(Cambridge Isotope Laboratories) or L-[13C6,15N4]-arginine (Sigma-Aldrich) and L-[13C6,15N2]-
lysine (“heavy” form) (Cambridge Isotope Laboratories). To achieve complete incorporation of 
SILAC amino acids, cells were cultured in a SILAC medium for at least five doubling and 
labeling efficiency was confirmed by a mass spectrometry.  
 
Mouse embryonic stem cells (E14, 6th passage) were kindly provided from Michel Vermeulen 
lab (Radboud Institute for Molecular Life Sciences) and cultured in collagen coated plates with 
DMEM high glucose media (life technologies) supplemented with 15% mESC compatible FBS 
(Hyclone cat no. SV30180.03, lot SZB20006), 1% non-essential amino acids (life technologies), 
0.1 mM ß-mercaptoethanol (Sigma-Aldrich), 1% penicillin and streptomycin (life technologies), 
leukemia inhibitory factor (LIF; 1,000 U/mL) (ESG1107, Merk Millipore) and 2i (3 µM 
CHIR99021 and 1 µM PD0325901) (130-104-170, Miltenyi Biotec). For the polysome proteome 




Murine B cell lymphoma line, 19PP, was established from Rag2-/-γC-/- mouse reconstituted 
with Cγ1-Cre; Myc/P110*flSTOP mouse BM cells (Sander et al., 2012). 19PP cells were 
transfected with Flp-expressing plasmid to delete GFP and hCD2 reporter genes. Reporter 
negative subline, 19DN, was established by FACS sorting of reporter double-negative 19PP 
cells. 19DN cells were maintained in DMEM medium (Gibco) containing 10% heat inactivated 
FBS, glutamax, sodium pyruvate, HEPES, non-essential amino acids, penicillin streptomycin (all 
1%) and 52 µM β-mercaptoethanol. 
 
METHOD DETAILS 
Sucrose Density Gradient Centrifugation 
On day of experiment, cells were grown to 80% confluency (one 15 cm plate per condition) and 
incubated with cycloheximide (CHX, 100 µg/mL) for 5 min at 37 oC before harvesting. Cells 
were washed with ice cold PBS containing CHX (100 µg/mL) and lysed with 300 µL of polysome 
lysis buffer [10 mM HEPES pH 7.4, 150 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 0.5% NP-40, 
EDTA-free protease inhibitor cocktail (Roche), SUPERaseIn (Thermo Fischer Scientific, 
AM2696, 20 U/µL) and 100 µg/mL CHX)]. After lysing the cells by passing ten times through 21 
gauge needle, cell debris was removed by centrifugation (20,000 g, 10 min, 4 oC). The 
supernatant was then layered onto a 10 mL linear sucrose gradient 15–45% (w/v), 
supplemented with 10 mM HEPES pH 7.4, 150 mM KCl, 5 mM MgCl2, 0.5 mM DTT and 100 
µg/mL CHX and centrifuged (36,000 rpm, 150 min, 4°C) using a Sorvall WX 90 ultracentrifuge 
(Thermo Fisher Scientific). Approximately 40 fractions (250 µL each) from each condition were 
collected using a gradient station (Biocomp). For polysome proteome profiling by mass 
spectrometry, cell lysates from different labeling states were individually resolved by density 
gradient centrifugation. Each individual fraction from light and heavy cells were combined as 
biological duplicate. For medium-heavy cells, all fractions were pooled and subsequently 
spiked-in each fraction from the combined light and heavy mixtures as an internal standard. For 
the polysome proteome profiling of mESCs, heavy-labeled NIH3T3 cells were used an internal 
standard (see Figure S1) as cell culture medium and serum for SILAC labeling of mESCs are 
not commercially available.   
 
Sample Preparation for Proteome Analysis  
Proteins from the fractionated samples were precipitated with 20% trichloroacetic acid (TCA) 
and the precipitated pellets were washed three times with ice-cold acetone. The remaining 
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solution was evaporated by a speedvac (Eppendorf™ Vacufuge™ Concentrator). Protein pellets 
were resuspended in 50 µL of 8 M urea and 0.1 M Tris-HCl, pH 8. Proteins were reduced with 
10 mM dithiothreitol (DTT) at room temperature for 30 min and alkylated with 50 mM 
iodoacetamide (IAA) at room temperature for 30 min in the dark room. Proteins were first 
digested by lysyl endopeptidase (LysC) (Wako) at a protein-to-LysC ratio of 100:1 (w/w) at room 
temperature for 3 hr. Then, the sample solution was diluted to final concentration of 2 M urea 
with 50 mM ammonium bicarbonate (ABC). Trypsin (Promega) digestion was performed at a 
protein-to-trypsin ratio of 100:1 (w/w) under constant agitation at room temperature for 16 hr. 
Peptides were desalted with C18 Stage tips and further cleaned up with SCX (strong cation 
exchange chromatography) Stage tips and desalted again with C18 Stage tips (Rappsilber et 
al., 2007) prior to LC-MS/MS analysis.  
 
For other standard proteome samples, cells were lysed in  50 µL of 8 M urea and 0.1 M Tris-
HCl, pH 8. Protein reduction, alkylation and digestion were performed as described above. 
Peptides were desalted with a C18 Stage tip before LC-MS/MS analysis.  
 
Phosphopeptide Enrichment 
For the density gradient samples are exactly same as the ones used for polysome proteome 
profiling (see "Sucrose Density Gradient Centrifugation"), two adjacent fractions were combined 
in order to increase starting material for phosphopeptide enrichment. Peptides were 
resuspended in 100 µL of loading buffer [80% ACN (vol/vol) and 6% TFA (vol/vol)]. 
Phosphopeptides were enriched using a microcolumn tip packed with 0.5 mg of TiO2 
(Titansphere, GL Sciences) (Rappsilber et al., 2007) and following steps were performed at 4 
oC. The TiO2 tips were equilibrated with 20 µL of the loading buffer via centrifugation of 100 g. 
50 µL of the sample solution was loaded on a TiO2 tip via centrifugation of 100 g and this step 
was repeated until the sample solution was completely loaded. The TiO2 column was washed 
with 20 µL of the loading buffer, followed by 20 µL of washing buffer [50% ACN (vol/vol) and 
0.1% TFA (vol/vol)]. The bound phosphopeptides were eluted using successive elution with 30 
µL of elution buffer 1 (5% ammonia solution), followed by 30 µL of elution buffer 2 (5% 
piperidine) (Kyono et al., 2008). Each fraction was collected into a fresh tube containing 30 µL 
of 20% formic acid. 3 µL of 100% formic acid was added to further acidify the samples. The 
phosphopeptides were desalted with C18 Stage Tips prior to LC-MS/MS analysis.  
 
NanoLC-MS/MS Analysis  
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Reversed-phase liquid chromatography was performed by employing an EASY nLC II , 1000 or 
1200 (Thermo Fisher Scientific) using self-made fritless C18 microcolumns (Ishihama et al., 
2002) (75 µm ID packed with ReproSil-Pur C18-AQ 3-µm resin, Dr. Maisch GmbH) connected 
on-line to the electrospray ion source (Proxeon) of a Q Exactive mass spectrometer or Q 
Exactive plus (Thermo Fisher Scientific). The mobile phases consisted of (A) 0.1% formic acid 
and 5% acetonitrile and (B) 0.1% formic acid and 80% acetonitrile. For the fractionated 
samples, peptides were eluted from the analytical column at a flow rate of 200 nL/min by 
altering the gradient: 5-6% B in 2 min, 6-8% B in 14 min, 8-20% B in 44 min, 20-33% in 50 min, 
33-45% B in 12 min, 45-60% B in 2 min and 60-95% B in 1 min. Phosphopeptides were 
separated on a 2 m monolithic column (Miyamoto et al., 2008) [MonoCap C18 High Resolution 
2000 (GL Sciences), 100 mm i.d. x 2,000 mm] at a flow rate of 300 nL/min by altering the 
gradient: 5-6% B in 2 min, 6-8% B in 18 min, 8-20% B in 80 min, 20-33% in 80 min, 33-45% B in 
20 min, 45-60% B in 2 min, 60-95% B in 1 min. The Q Exactive (plus) instrument was operated 
in the data dependent mode with a full scan in the Orbitrap followed by top 10 MS/MS scans 
using higher-energy collision dissociation (HCD). For standard proteome analyses, the full 
scans were performed with a resolution of 70,000, a target value of 3x106 ions and a maximum 
injection time of 20 ms. The MS/MS scans were performed with a 17,500 resolution, a 1x106 
target value and a 60 ms maximum injection time. For phosphoproteome analyses, the full 
scans were performed with a resolution of 70,000, a target value of 3x106 ions and a maximum 
injection time of 120 ms. The MS/MS scans were performed with a 35,000 resolution, a 5x105 
target value and a 160 ms maximum injection time. Isolation window was set to 2 and 
normalized collision energy was 26. Ions with an unassigned charge state and singly charged 
ions were rejected. Former target ions selected for MS/MS were dynamically excluded for 30 s.  
 
Parallel Reaction Monitoring (PRM) assay 
 
50 randomly selected proteins from the shotgun experiment with log2 fold changes > 0.1 and < -
0.1 were selected to be reanalyzed with PRM (Peterson et al., 2012) (see Table S5 for the 
complete list). We additionally included a set of 10 proteins within the range of -0.2 and 0.2 log2 
fold change that served as an internal control. The inclusion list for the PRM method was 
generated using Picky (Zauber et al., 2018) with SILAC option enabled (including Lys4 and Arg6 
as medium-heavy and Lys8 and Arg10 as heavy label), a retention time window of 50 min and 
setting the species to mouse. Predicted retention-times were calibrated in Picky with a complex 
sample of tryptically digested E. coli proteome immediately before the start of the PRM 
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measurements. Peptides were separated by reverse phase chromatography on an effective 200 
min gradient and analyzed on a Q-Exactive HFx (Thermo Fisher Scientific). The PRM settings 
were: 15,000 resolution; 2x105 AGC target; 1.6 m/z isolation window; 40 ms maximum ion 
injection time.  
 
Processing of Mass Spectrometry Data  
All raw data were analyzed and processed by MaxQuant (v1.5.1.2) (Cox and Mann, 2008). 
Default settings were kept except that ‘match between runs’ was turned on. Search parameters 
included two missed cleavage sites, cysteine carbamidomethyl fixed modification and variable 
modifications including methionine oxidation, protein N-terminal acetylation, deamidation of 
glutamine and asparagine as well as phosphorylation of serine, threonine and tyrosine 
(phosphoproteomics only). The peptide mass tolerance was 6 ppm and the MS/MS tolerance 
was 20 ppm. Database search was performed with Andromeda (Cox and Mann, 2008; Cox et 
al., 2011) against UniProt/Swiss-Prot human or mouse database (downloaded on 2014-11) with 
common serum contaminants and enzyme sequences. False discovery rate (FDR) was set to 
1% at peptide spectrum match (PSM) level and at protein level. A minimum peptide count 
required for protein quantification was set to two. Normalized SILAC ratios were used for all 
analyses in this study except that non-normalized SILAC ratios were used for polysome 
proteome profiling to quantify relative abundance of individual proteins across density gradient 
fractions. Phosphorylation sites were ranked according to their phosphorylation localization 
probabilities (P) as class I (P > 0.75) (Olsen et al., 2006) and only class I sites were used for 
further analyses. Phosphorylation site occupancy was calculated based on the observed SILAC 
ratio for the phosphopeptide, the SILAC ratio for the non-phosphorylated peptide and the SILAC 
ratio of the protein (Olsen et al., 2010) using MaxQuant.   
 
Data Analysis of PRM Measurements 
Traces of all fragments from precursors in the spectral library (as exported from Picky) were 
extracted from all raw files using the Thermo MSFileReader software and the MSFileReader.py 
bindings written by François Allen. For each medium or heavy scan the normalized spectral 
contrast angle (SCN) was calculated (Toprak et al., 2014). Peaks were manually validated and 
required to have a SCN > 0.3 and >= 4 matched fragments in the medium or heavy channel. 
Further, peaks needed to be within a similar retention time range across all different 
measurements. From 50 proteins selected for PRM, 41 passed the quality filters and were thus 
included in the subsequent data-analysis. Ratios for each fragment using the maximum intensity 
	
40	
of each peak were calculated. All ratios were corrected by the median log2 fold ratio shift 
observed among all controls. The median log2 transformed ratio (log2FC) for each peptide in 
each raw-file was calculated from selected fragment ratios: The ten highest abundant fragments 
were selected from the peak with the highest detected SCN. Protein log2 FC were individually 
tested for differential significance against 0 using a one sided t-test (p <= 0.05). All peptide log2 
FCs for a protein across all experiments (8 hr, 16 hr, label-swap experiments and two technical 
replicates) were therefore included in the test. 
 
Estimation of Protein Abundance Using iBAQ 
For each individual protein, intensity-based absolute quantification (iBAQ) algorithm 
(Schwanhäusser et al., 2011) computes the sum of all the peptides intensities divided by the 
number of theoretically observable peptides, which provides us rough estimation of protein 
abundance. To estimate protein abundance in the polysome fractions, iBAQ intensities of each 
protein was summed up from all polysome fractions and an average of summed iBAQ values 
from replicates was used for Figure 2H. 
 
Generation of HEK293 Stable Cell Lines Expressing FLAG/HA-RPL12 
RPL12 wild-type, S38A or S38D mutant coding sequences were recombined using LR Clonase 
II (Gateway, Thermo Fisher Scientific) into pFRT/TO/FLAG/HA-DEST (Addgene ID: 26360). The 
resulting vectors were used to generate stable HEK293 Flp-In T-Rex cells lines overexpressing 
FLAG/HA-tagged wild-type RPL12, or S38A and S38D RPL12 mutated proteins. Briefly, 
HEK293 Flp-In T-Rex cells were transfected in a 12-well format by mixing 100 µL of Opti-MEM 
with 1 µg of total plasmid DNA (9:1 ratio of pOG44 to destination vector) and 2 µL of 
Lipofectamine 2000 (Thermo Fisher Scientific). After a 5 min incubation, the transfection mixture 
was added to the cells. Cells were re-seeded into 10 cm dishes after 48 hr and allowed to attach 
overnight. Hygromycin (100 µg/mL, InvivoGen) was added the next day and the cells were 
selected for 2-3 weeks by the addition of fresh hygromycin-containing cell culture media every 
2-3 days resulting in expansion of monoclonal colonies.  
 
Generation of RPL12 Point Mutant Cell Lines via CRISPR/Cas9 
RPL12-S38A and RPL12-S38D point mutant cells were generated by CRISPR/Cas9-mediated 
double strand break and homologous recombination. To generate pX330-Cas9-RPL12sgRNA 
plasmid, following synthetic oligos were annealed, phosphorylated and ligated into BbsI site of 




AAACACTTTCTTCGGAGACTGTAGC-3'. For several known pseudo genes, specific targeting 
of RPL12 coding gene was confirmed by T7 assay using PCR primers of RPL12 seqfw 5’-
TACTGCAGAGTTGTCTTAGTGAAGAAGG-3’ and RPL12 T7rev 
5’-GCTCCTTGAGGGCTTTGATGATCAGG-3’ and lethality of homozygous mutants after 
electroporation into 19DN cells. To generate donor templates for knock-in, RPL12-S38A and 
RPL12-S38D PCR fragments were amplified from 19PP genomic DNA using following primers. 




5’-CGGAATTCCAGAAAGTTCTCTAGCCAAAGACCGGTGTC-3’. For RPL12-S38D donor 
template, BamHI-5HAfw 5’-CGGGATCCGTCTTTTCGGCTTTCGGCTCGGAGG-3’, S38Drv 5’-
CCAACTTTCTTCGGGTCCTGTAGAAATAATAGCATTCGTTACCATGTGCC-3’, S38Dfw 
5’-GAATGCTATTATTTCTACAGGACCCGAAGAAAGTTGGCGATGACATTGCC-3’, EcoRI-
3HArv 5’-CGGAATTCCAGAAAGTTCTCTAGCCAAAGACCGGTGTC-3’. PCR fragments were 
digested by BamHI/EcoRI and ligated into BamHI/EcoRI sites of pBluescript II SK(+) vector for 
sequencing confirmation and to use as PCR template. To generate knock-in cell lines, pX330-
Cas9-RPL12sgRNA plasmid and donor template were electroporated into 19DN cells by the 
Nucleofector 2b (Lonza) with X01 program. mCherry positive cells were FACS sorted on day 2 
after the electroporation. After 3 days of mCherry positive cell culture, single cells were FACS 
sorted in 96 well plates. Genomic DNA was isolated from single cell clones using QuickExtract 
DNA Extraction Solution (Epicentre). Knock-in clones were identified by the PCR screening 
using KOD DNA polymerase (Merck Millipore) with following knock-in specific primers and 
external primer after the optimization of annealing temperatures. For RPL12-S38A screening, 
RPL12 exfw 5’- CGAGAGCTGAGCTTTTCCGCCTATATCC-3’ and RPL12 A38rev 5’-
ATGTCATCGCCAACTTTCTTCGGGGC-3’. For RPL12-S38D screening, RPL12 exfw 5’- 
CGAGAGCTGAGCTTTTCCGCCTATATCC-3’ and RPL12 D38rev 5’- 
ATGTCATCGCCAACTTTCTTCGGGTC-3’. Homozygous knock-in clones were further selected 
by DNA sequencing to use in this study (Figure S5A). Cell sorting was done on a FACS Aria II 
(BD Biosciences). The mutations of the homozygous knock-in clones were further verified by 
LC-MS/MS; heavy-labeled parent cells were spiked into each knock-in clone, and  knock-in 




Western Blotting of Sucrose Density Gradient Fractions  
HEK293 cells were lysed with the polysome buffer and the lysate was either treated with DMSO 
(control) or 10 mM EDTA. Following density gradient centrifugation, fractionation and protein 
precipitation were done as described above (see “Sucrose Density Gradient Centrifugation”). 
Each sample was re-suspended in 1 x LiDS loading sample buffer (Invitrogen) with 50 mM DTT 
and incubated at 70 oC for 5 min. The protein samples were loaded onto a 4%–12% gradient 
SDS-polyacrylamide gel (Thermo Fisher Scientific) and separated using electrophoresis. The 
proteins were then further transferred to a PVDF membrane (Merck Millipore) using a wet 
western blot contraption (Invitrogen) set to a constant current of 250 mA for 1 hr. The 
membranes were first blocked by incubating in 5% milk powder in Tris-buffered saline and 1% 
tween (TBS-tween) and then incubated with the protein specific antibody [anti-HA (sc-805 HA-
probe Y-11, Santa Cruz), anti-RPL12 (PA5-31670, Thermo Fisher Scientific), anti-RPS5 (A304-
011A, Bethyl Laboratories), anti-NUFIP2/82-FIP antibody (A301-600A-T, Bethyl Laboratories), 
anti-GPATCH4 antibody (A303-405A-T, Bethyl Laboratories), anti-LLPH antibody 
(SAB1302290), UQCRC2 antibody (GTX114873, GeneTex), H1FX antibody (ASB-OAAB10031, 
Aviva), anti-C11orf48 antibody (TA331749, Origene) and anti-C7orf50 antibody (20797-1-AP, 
Proteintech)] diluted 1:1,000 in 5% milk in TBS-tween overnight while rotating at 4 oC. 
Membranes were washed three times in TBS-tween and then incubated with secondary HRP-
conjugated anti-rabbit or anti-mouse antibody (Sigma-Aldrich) diluted in 1:10,000 before being 
incubated with horseradish peroxidase (Merck Millipore).  
 
AHA Labeling and Flow Cytometric Analysis 
HEK293 and B cells were starved in methionine-free medium for 30 min and pulsed labeled with 
1 mM azidohomoalanin (AHA) (Anaspec) for 30 min. Cells were then washed with ice-cold PBS 
and fixed in 4% PFA in PBS for 15 min at room temperature. Fixed cells were permeabilized 
with 1% BSA with 0.1% saponin in PBS for 15 min at room temperature and washed with 1% 
BSA in PBS.  The click reaction was performed by incubating cells with 100 µL of the reaction 
mixture per sample [1 µM Alexa Fluor 488 alkyne (Thermo Fisher Scientific), 10 mM sodium 
ascorbic acid (Sigma-Aldrich) and 2 mM CuSO4 (baseclick)] for 30 min in a dark room. After the 
click reaction, cells were washed once with 1% BSA. Then, cells were incubated with phospho-
histone H3 Ser10 antibody (Cell Signaling Technology) and anti FLAG-biotin antibody (Miltenyi 
Biotec) (1:100 dilution, HEK293 only) for 1 hr at room temperature. After washing cells twice 
with 1% BSA, PE-Cy7 streptavidin secondary antibody (BioLegend) (1:400, HEK293 only) was 
added to samples and incubated for 30 min and then cells were washed twice with 1% BSA. 
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Cells were resuspended in FACS buffer (1% FCS, 1mM EDTA, 0.05% NaN3 in PBS). Flow 
cytometric analysis was performed on a FACS Aria instrument (BD Biosciences). FLAG/HA 
RPL12-expressing HEK293 cells were gated for measuring protein synthesis and cell cycle 
profile. 
 
Pulsed SILAC (pSILAC) 
HEK293 cells were seeded in SILAC “light” DMEM in a 6 well plate, and the following day cells 
were 40% confluent and transient transfections were performed using linear polyethylenimine 
(Sigma-Aldrich) with 2 µg plasmid DNA encoding RPL12-WT, -S38D or -S38A and 6 µg PEI per 
condition). After 72 hr post-transfection, cells were transferred to either SILAC “medium-heavy” 
or “heavy” media, respectively. After 24 hr pulse labeling, cells were harvested and combined, 
and proteins were digested to peptides as described above (see “Sample Preparation for 
Proteome Analysis”). For pSILAC and PRM assay using knock-in mouse B cells (60-70% 
confluent on the day of experiments), RPL12 S38D cells and RPL12 S38A cells were pulse 
labeled with either "medium-heavy" or "heavy" amino acids for 8 hr (both pSILAC and PRM 
assay) and 16 hr (PRM only). Label swap experiments were performed.  
 
Immunoprecipitation of FLAG/HA-tagged RPL12 from Sucrose Gradient Fractions and 
Library Preparation 
Cycloheximide (50 µg/mL) was added to each pooled 80S fraction (1 mL) obtained by sucrose 
gradient fractionation (Figure S4B). Aliquots of these input fractions were used for Western blot 
analysis (20 µL) and total RNA extraction with Trizol (50 µL). The rest of the sample was 
subjected to anti-FLAG immunoprecipitation. To prepare anti-FLAG conjugated magnetic beads, 
15 µL of Dynabeads Protein G (Thermo Fisher Scientific) were used per sample, washed twice 
in 0.02 % of Tween 20/PBS (PBST) and resuspended in 30 µL of PBST containing 0.25 µg/µL 
anti-FLAG M2 monoclonal antibody (F3165, Sigma Aldrich). After a 1 hr incubation at room 
temperature with rotation, the beads were washed twice in PBST, resuspended into the 
fractionated sample, followed by incubation at 4 °C for 90 min. Next, the beads were 
concentrated and the supernatants removed, followed by 4 washing steps in 1 mL of washing 
buffer [0.05% (v/v) IGEPAL-CA630, 50 mM Tris pH 7.5, 150 mM KCl, 0.5 mM DTT, 50 µg/mL 
CHX, 1x complete EDTA-free protease inhibitor cocktail (Roche)]. Before concentrating the 
beads during the fourth washing step, 100 µL of suspension was removed for Western blot 
analysis, while the rest of the sample was used for RNA extraction. After the concentration of 
beads and removal of the supernatant, the beads were either resuspended in 1 bead volume of 
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2x Laemmli sample buffer (Western analysis) or 1 mL of Trizol (RNA extraction). After standard 
Trizol extraction consisting of chloroform addition and centrifugation, the clean-up of the 
aqueous phase was carried out using miRNAeasy kit (Qiagen) according to manufacturer’s 
instruction.  
 
Extracted RNA (either 1 µg of input samples or all of the immunoprecipitated material) was 
treated with 0.4 U Turbo DNase (Thermo Fisher) for 30 min at 37 ºC, phenol-chloroform 
extracted, ethanol-precipitated and resuspended in water.  
 
For input samples, equal amounts of total RNA (1 µg) and 2 µL of 1:100 dilution of ERCC Spike-
in Control Mix 1 (Thermo Fisher Scientific) were mixed and adjusted to 50 µL final volume with 
water. All immunoprecipitated material per sample was mixed with 2 µL of 1:100 dilution of 
ERCC Spike-in Control Mix 1 and adjusted to 50 µL final volume with water. These 50-µL 
samples were then input into the Truseq stranded mRNA kit (Illumina) using 2 rounds of oligo-
dT enrichment. Manufacturer's instructions were followed in all subsequent steps. cDNA 
libraries from different samples were multiplexed using Illumina RPI oligonucleotides and 
sequenced by multiplexing 6 samples per lane on a HiSeq 2000 instrument using 1x101+7 
cycles. 
 
RNA-seq Data Processing and Analysis 
Basecalls were converted to fastq files using Bcl2Fastq (v2.16.0.10). Next, the reads were 
demultiplexed and adapter sequences removed by Flexbar (v2.5) utilizing Illumina RPI index 
barcodes. Reads were then collapsed to remove PCR duplicates using collapse_reads.pl script 
(Jens, 2016; Lebedeva et al., 2011) and aligned to the human genome (version hg19) using the 
STAR aligner 2.4.2a with read counting mode enabled to obtain count tables. To account for the 
variability between input samples, we normalized the read counts by DESeq2-computed size 
factors (Love et al., 2014) obtained from ERCC spike-in read counts in the input samples. The 
same procedure was also applied to IP samples by using ERCC spike-in read counts from the 
IP samples. Next, pairwise comparisons of IP sample vs. input read counts were performed by 
DESeq2 using standard parameters. Log2-transformed fold changes provided in the DESeq2 
output were used to quantify mRNA enrichment in IP vs. input.  
 
To assess the effect of RPL12 mutations on translation during different cell cycle stages, we 
classified the immunoprecipitated mRNAs according to their enrichment values. Specifically, for 
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all positive log2-transformed enrichment values we calculated the difference in enrichment 
between three conditions (WT vs. S38A, WT vs. S38D or S38D vs. S38A). Next, we used R’s 
quantile function to obtain three equally sized groups of mRNAs that showed high, unchanged 
and low enrichment in one condition. Distributions of changes in ribosome occupancy (mitosis 
vs. S phase) (Stumpf et al., 2013) for these three different groups of mRNAs were plotted (Fig. 
5B) and Wilcoxon rank sum test to assess significant differences between them was used. 
 
To assess sequence characteristics of precipitated mRNAs we first matched RNAseq data to 
coding sequences (release 91, from ensembl.org)  based on ENSEMBL Gene ID. We 
considered one coding sequence per gene by removing duplicate entries. We then calculated 
frequencies for all 64 codons or the overall GC content and related them to the log2 D/A 
enrichment values across all matched genes. Spearman correlation coefficients of the individual 
pairwise comparisons are given and indicate the strength of the individual relationships. 
 
For the comparison to transcriptional data we downloaded tables S5 (mitotically-expressed 
transcripts, here denoted as transcribed in mitosis) and S7 (mitotically-enriched transcripts, here 
denoted as transcriptionally induced in mitosis) from a dataset about mitotic transcription 
(Palozola et al., 2017). We matched transcripts to log2 D/A enrichment values from RNAseq 
data via ENSEMBL Gene IDs using db2db tool of bioDBnet (Mudunuri et al., 2009). Again, we 
considered one transcript per gene by removing duplicate entries. Further, we removed all 
entries in “transcriptionally enriched in mitosis” from “transcribed in mitosis”. GC content of 
these gene sets was calculated as described above.  
 
Ribosome Profiling for mouse B cells 
The mouse B cells were cultured in two 15 cm plates per condition until 60-70 % confluent and 
incubated without treatments or with 100 ng/mL nocodazole (Sigma-Aldrich) for 8 hr to 
synchronize the cells in mitosis. Nocodazole was then released by washing the cells twice in 
pre-warmed PBS, and the cells were further incubated in fresh medium for 10 min before 
harvesting cells. Cellular DNA content was measured by flow cytometry (Figure S6G).  
 
To verify expected changes in the abundance of mitotic marker proteins between asynchronous 
and nocodazole-treated cells, heavy-labeled asynchronous cells were spiked into the 
nocodazole-treated cells, and subsequent procedures including cell lysis, tryptic digestion and 




We followed the original protocol (Ingolia et al., 2012) with minor modifications (Calviello et al., 
2015). Cell pellets were flash-frozen in liquid nitrogen, transferred to ice and lysed in 
mammalian polysome buffer [20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 
100 µg/mL CHX), supplemented with 1% (v/v) Triton X-100 and 25 U/mL TurboDNase (Thermo 
Fisher Scientific)]. Afterwards, lysates were triturated ten times through a 26-gauge needle, 
cleared by centrifugation (20.000 xg, 5 min, 4 oC), flesh frozen in liquid nitrogen and stored at -
80 oC. To obtain ribosome-protected fragments, lysates (120-µL aliquots) were treated with 3 µL 
of RNase I (Ambion, AM2294, 100 U/µL) for 45 min at room temperature with slow agitation. 
RNase activity was inhibited by the addition of 4 µL of SUPERaseIn (Thermo Fischer Scientific, 
AM2696, 20 U/µL). Meanwhile, MicroSpin S-400 HR columns (GE Healthcare, 27-5140-01) 
were equilibrated with 3 mL of mammalian polysome buffer without DTT and CHX by gravity 
flow and emptied by centrifugation at 600 x g for 4 min. We then immediately loaded 100 µL of 
the digested lysate on the column and eluted the column by centrifugation at 600 x g for 2 min. 
We extracted RNA from the flow-through (approximately 125 µL) using Trizol LS (Life 
Technologies, 10296-010) in combination with the RNA Clean & Concentrator kit (Zymo 
Research). We then depleted ribosomal RNA fragments using the RiboZero Kit (Illumina, 
MRZH11124) and separated the remaining RNA on a 17% denaturing urea-PAGE gel (National 
Diagnostics, EC-829). The size range from 27 nt to 30 nt, defined by loading with 20 pmol each 
of Marker-27 nt and Marker-30 nt, was cut out, and the RNA fragments were subjected to small 
RNA cloning and library generation (Hafner et al., 2012) using 3′ adaptor 4N-RA3, 5′ adaptor 
OR5-4N, RT primer RTP and PCR primers RP1 (forward primer) and RPI1-12 (reverse primer, 
containing barcodes, for sequences see Illumina Truseq small RNA oligonucleotides).  
To obtain matching 3’ mRNA-seq datasets for mRNA quantification, we isolated total RNA from 
mammalian polysome buffer lysates (120-µL aliquots, see above) using Trizol LS. Next, 1 µg of 
total RNA was mixed with 1 µL of 1:50 dilution of ERCC Spike-in Control Mix 1 (Thermo Fisher 
Scientific), TurboDNase-treated and input into QuantSeq 3’ mRNA-Seq Library Prep Kit FWD 
(Lexogen, Inc.). Subsequent steps were performed according to manufacturer’s instruction. All 
cDNA libraries were multiplexed at 12 samples per lane and sequenced on a HiSeq 2500 
instrument using 1x51+7 cycles. 
 
The following oligonucleotides were used for ribosome profiling: 
Marker-27 nt, 5′-rArUrGrUrArCrArCrGrGrArGrUrCrGrArGrCrUrCrArArCrCrCrGrC-P;  




4N-RA3, 5’-rApp-NNNNTGGAATTCTCGGGTGCCAAGG-InvdT;  
OR5-4N, 5′-rGrUrUrCrArGrArGrUrUrCrUrArCrArGrUrCrCrGrArCrGrArUrCrNrNrNrN; 
 
Ribosome Profiling Data Processing and Analysis 
Basecalls were converted to fastq files using Bcl2Fastq (2.16.0.10). For the ribosome profiling 
dataset, reads were demultiplexed and adapter sequences removed by Flexbar (2.5). Reads 
were then collapsed to remove PCR duplicates, followed by removal of random nucleotides 
(four on both 5’ and 3’ end of the reads) using fastx_trimmer (FASTX Toolkit 0.0.14). Reads 
aligning to rRNA sequences were removed by Bowtie2 (2.3.2) and the remaining sequences 
were aligned to the mouse genome (mm10) using STAR aligner (2.5.3a). The STAR genome 
index was built using annotation obtained from GENCODE (M14). Next, reads of 29 or 30 
nucleotides in length were retained and counted in coding sequence (CDS) exons (-t CDS) 
using HTSeq-count (0.9.1). Quality control of ribosome profiling data was performed using 
RiboTaper (Calviello et al., 2015) and riboWaltz (Lauria et al., 2017).  
For the 3’ mRNA-seq dataset, reads were demultiplexed by Flexbar (2.5) and adapter 
sequences removed by cutadapt (1.12). Next, reads were aligned to the mm10 genome using 
the STAR aligner 2.5.3a with read counting mode enabled to directly obtain read count tables.  
To detect differences in translational efficacy, as well as in mRNA abundance and both effects 
(transcription and translation) we used DESeq2 (1.18.1) with an interaction term model as 
described (Chothani et al., 2017). Briefly, RPF read counts were normalized using the DESeq2 
estimateSizeFactors function by taking into account all read counts. For 3’ mRNA seq, ERCC 
spike-in read counts were used to obtain normalization factors using the same function. 
DESeq2 was run with default parameters. We considered genes with P-adjusted value <0.1 and 
log2-transformed fold change >0 to be differentially translated between parent mitotic vs parent 
asynchronous conditions. Log2-transformed fold changes for downstream comparisons were 
taken directly from the DESeq2 output.  
 
Identifying ribosome-associated proteins using mean squared deviation (MSD) 
To identify ribosome-associated proteins within 40S, 60S and polysome fractions we compared 
abundance profiles of individual proteins with corresponding consensus profiles by computing 
MSD values (Andersen et al., 2003; Foster et al., 2006). First, to define consensus profiles of 
40S, 60S and polysomes we used the following fractions #2-14, #6-14 and #15-36 as 40S, 60S 
and polysome fractions, respectively (see Figure S2A). Non-normalized SILAC ratios were first 
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transformed into log2 space and then average profiles of core RPs across corresponding 
fractions were used as 40S, 60S and polysome consensus profiles. We only considered protein 
profiles that were quantified at least in four and ten fractions for 40S/60S and polysome 
fractions, respectively. We then compared individual protein profiles with the corresponding 
consensus profiles of 40S, 60S or polysome using MSD values. MSD was calculated as follows: 
the squared deviation of the profile for individual proteins was divided by the number of data 
points (Andersen et al., 2003; Foster et al., 2006) (see Figure 2B). Observed distribution of MSD 
values in HEK293 was shown in Figure 2C. To discriminate true positive interactors from false 
positive based on MSD values, we used a statistical analysis using a simulated false discovery 
rate (FDR). To this end, we generated a shuffled dataset where the protein profiles (that is, 
SILAC ratios) were shuffled for each individual fraction among the proteins and MSD values 
were calculated for the shuffled dataset as well (see Figure 2C grey bars). The cut-off was 
chosen as the (lowest) MSD value from 100 independent shuffling operations (nominal FDR=0) 
of individual replicates (dash line in Figure 2C). We categorized two sets of proteins as potential 
polysome associated. For category one, a potential polysome associated protein was required 
to be above the threshold in both replicates from at least one cell line. For category two,a 
protein was required to be above the threshold in at least one replicate. The best MSD value 
from both replicates was considered the final MSD value in the respective cell line (see Figure 
2C).  
  
The performance of our polysome proteome profiling approach was assessed by receiver-
operator-characteristics (ROC). To do this, we first defined a set of true positive (a reference 
set) and true negative polysome associated proteins (shuffled protein profiles (see above)). The 
reference set includes proteins that are known to be ribosome related based on GO terms, 
STRING protein interaction database (Szklarczyk et al., 2017) and RNAi data (Badertscher et 
al., 2015; Wild et al., 2010) (see Table S2 for a complete list of the reference). The false positive 
rate and true positive rate were plotted at different MSD thresholds once including and once 
excluding ribosomal proteins as true positives (Figure 2E) and the plot in Figure 2E is based on 
the data of replicate 1 in HEK293 cells. For interaction mapping at subunit level (related to 
Figures 2J and S2C) a threshold of 0.7 -log10(MSD) was set to separate 40S/60S interacting 
proteins from background. 
 
For calculating MSD values for phospho-sites we used their non-log ratios over the entire 
gradient and used the protein corresponding to the respective phosphopeptide as a reference 
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profile. We required the phosphopeptide to be quantified in at least one fraction, same as the 
respective phosphoprotein. The best MSD value from both replicates was considered the final 
phospho MSD for the respective cell line (see Figure 3B). Calculations were performed using in-
house made R-scripts. 
 
 
Protein Complex Enrichment Analysis 
 
We compared the polysome associated proteins to “riboproteome” from a previous study 
(Reschke et al., 2013). For comparison to the data from Reschke et al., we matched IPI 
identifier to HGNC-approved symbols using the cross reference v.3.87. The depicted venn 
diagrams in Figures 2A and 2D are based on HGNC-approved symbols excluding ribosomal 
proteins. 
 
For protein complex enrichment analyses, we used a CORUM (the comprehensive resource of 
mammalian protein complexes) (Ruepp et al., 2010) core set database as a reference 
(Jan/2017). We tested two foreground sets of proteins, the polysome associated proteins (see 
above) and all proteins quantified at least one polysome fraction in both biological duplicates. 
The significance of protein complex enrichment was assessed with a Fisher’s Exact test using a 
Uniprot human protein database (Jan/2017) as background. An alpha of 0.01 was set for 
significance.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
The type of statistical test (e.g., Wilcoxon rank-sum or Fisher's exact test) is annotated in the 
Figure legend and/or in the Methods and Resources segment specific to the analysis. In 
addition, statistical parameters such as the value of n, mean/median, SEM, SD and significance 
level are reported in the Figures and/or in the Figure Legends. Statistical analyses were 
performed using R as described in Methods and Resources for each individual analysis. 
 
DATA AND SOFTWARE AVAILABILITY 
Data Resources 
Proteomic raw datasets have been deposited to the ProteomeXchange Consortium via the 
PRIDE partner repository with the dataset identifiers PXD009292 (Polysome 
(phospho)proteome profiling for HEK293 and HeLa),  PXD009268 (Polysome proteome profiling 
for mESC), PXD009307 (pSILAC in HEK293), PXD009267 (Polysome proteome profiling for B 
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cells), PXD009276 (pSILAC in B cells) and PXD010029 (PRM in B cells).  





Supplemental figure titles and legends 
Figure S1. Polysome proteome profiling for mESCs and profiles for ribosomal protein-
like proteins (related to Figure 1) 
(A) Experimental setup for 3P in mESCs. Mouse ES cells were grown in a standard cell culture 
medium. NIH3T3 cells labeled with "heavy" SILAC amino acids served as a reference. The 
procedure is the same as described in Figure 1. (B) Abundance profiles for individual ribosomal 
proteins (40S and 60S proteins are shown in blue and red, respectively) across density gradient 
fractions. (C) Representative profiles for ribosomal protein-like proteins (RPL22L1/eL22L1, 
RPL26L1/uL24L1 and RPL7L1/uL30L1) in HEK293. See Figure S3 for the all profiles. 
❡ 
Figure S2. Interaction mapping and validation (related to Figure 2) 
(A) A schematic diagram showing density gradient fractions used for MSD calculation to map 
protein interaction with the 40S complex (fractions 2-14), 60S complex (fractions 6-14) and 
polysomes (fractions 15-36). (B) Correlation of polysome MSD values between HeLa duplicate 
samples (left) and between HEK293 and HeLa (right). Venn diagram representing the overlap of 
number of proteins identified in polysome fractions between two conditions is shown in the inset. 
(C) Mapping polysome interactome at subunit resolution in HeLa. (D) Validation for new 
polysome-associated proteins: Western blots for selected new candidates on sucrose gradient 
fractions in the absence (top) or presence (bottom) of EDTA. Western blots for RPs (RPS4/uS7 
and PPL12/uL11) are shown as positive controls. (E) 3P-based profiles for the candidate 
proteins (dark green) are shown and insets show respective Western blots. NUFIP2 is used as 
a positive control. 
❡  
Figure S3. Western blot analysis using HEK293 stable cell lines expressing FLAG/HA-
RPL12/uL11 (clone #2) (related to Figure 3) and RNA-seq analysis of monosome-
associated mRNAs (related to Figure 5) 
	
51	
(A) Western blots of sucrose gradient fractions using an anti-HA antibody with short (top) and 
long (bottom) exposure time. The results for these different clones are consistent with the 
results shown in Figure 3E. (B) Experimental procedure. FLAG/HA RPL12/uL11 monosome-
bound mRNAs were obtained by isolating monosomes from the corresponding density gradient 
fractions, followed by anti-FLAG immunoprecipitation (IP). (C) Immunoprecipitated mRNAs are 
classified according to their enrichment values (IP vs input). Specifically, for all positive log2 
enrichment values we calculated the ratio between three conditions (WT vs. S38A, S38D vs. 
S38A or WT vs S38D). Next, we used a quantile function to obtain three equally sized groups of 
mRNAs with high, unchanged and low ratios for a given comparison. (D) Distributions of 
changes in ribosome occupancy (mitosis vs. S phase) (Stumpf et al., 2013) for the three 
different groups of mRNAs were plotted. P values were calculated using one sided Wilcoxon 
rank sum tests. 
❡ 
Figure S4. Characterization of mouse B cells  (related to Figure 6) 
(A) Verifying RPL12 point mutation in mouse B cells: Sequencing results at the rpl12 target. 
Defined point mutations and homozygous knock-in clones were verified and selected using 
knock-in specific primers (see STAR method for the oligonucleotides used in this study). (B) 
Mass spectrometric analysis for the knock-in cell lines. “Heavy” SILAC labeled-parent cells were 
spiked into each knock-in cell line grown in a normal medium. Representative MS spectra for 
the tryptic peptides carrying corresponding point mutations are shown. The knock-in specific 
RPL12 peptides carrying the point mutations (S38D: IGPLGLDPK or S38A: IGPLGLAPK) were 
exclusively observed in the corresponding knock-in cell lines while the RPL12 WT peptide (WT: 
IGPLGLSPK) was exclusively observed in the parent cells. Note that an RPL12 peptide 
(EILGTAQSVGCNVDGR) not overlapping with the mutation site was observed in all the cell 
lines. (C) Experimental setup for 3P in mouse B cells. The parent cells labeled with "heavy" 
SILAC amino acids were served as a reference. The procedure is the same as described in 
Figure 1. (D) Averaged abundance profiles for individual ribosomal proteins (40S and 60S 
proteins are shown in blue and red, respectively) across the density gradient. RPL12's profiles 
are shown in purple. 
❡ 
Figure S5. pSILAC and ribosome profiling for mouse B cells (related to Figure 6) 
(A) Cumulative distribution function (CDF) plots of log2-fold changes (H/M ratios) of protein 
synthesis from the label swapping pSILAC experiment. P-values were computed using one-
sided Wilcoxon-rank sum test. (B) PRM based validation of observed fold changes between 
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S38A and S38D cells for 41 proteins selected from the pSILAC data. Green check marks 
indicate proteins that go into the right direction and are significant. Green check marks in 
parentheses indicate proteins that go into the right direction but are not significant. Red crosses 
indicate proteins that do not go into the right direction. P-values were computed using one-sided 
Wilcoxon-rank sum test. (C) Correlation heatmap of individual ribo-seq (top) and RNA-seq 
(bottom) read counts: high correlation is observed between the libraries. The numbers represent 
Pearson correlation coefficients. (D) The principal component analysis indicates that different 
cell lines and cell cycle stages can be clearly distinguishable based on the ribo-seq and RNA-
seq datasets. (E) RiboTaper output. Meta analysis of the periodicity of read starts around start 
codons. Number of reads at individual positions are shown. Colours correspond to different 
ORFs (0: green, +1: red,+2: blue). X-axis shows distance in nucleotides from the start codon. 
(F) Boxplots comparing pSILAC (Figure S5A) and ribosome profiling (Figure 6D) for the subsets 
based on log2 fold-changes (S38D/S38A) of the pSILAC data. P-values were computed using 
one-sided Wilcoxon-rank sum tests. (G) Representative DNA content profiles of asynchronous 
(straight lines) and nocodazole-treated (dashed lines) cells. Parent, S38D and S38A cells are 
shown in red, blue and light green, respectively. (H) Mitotic marker proteins exhibited higher 
abundance in the nocodazole-treated parent cells than in the asynchronous parent cells. To 
verify expected changes in the abundance of mitotic proteins in the nocodazole-treated cells, 
heavy-labeled asynchronous cells were spiked into the cells synchronized in mitosis. The 
scatter plot shows log2 fold-changes of the protein abundance (heavy-labeled asynchronous 
cells vs nocodazole-treated cells) between biological duplicate. Examples of known mitotic 
marker proteins are indicated by red dots. As expected, mitosis related GO terms such as "cell 
division" and  "cytokinesis" are overrepresented for the proteins that exhibited higher abundance 
(log2 FC < -0.5 in both replicates, red dash line in the figure) in the drug treated cells than in 
asynchronous cells. (I) GO enrichment analysis for 692 genes that are preferentially translated 
in mitosis compared to AS in wild-type B cells. Adjusted p-values by Benjamini–Hochberg are 
shown. 
 
Supplemental dataset title and legend 
Supplementary dataset. Profiles for all 145 identified polysome interactors (class I) and 
40 additional class II proteins (related to Figure 2) 
Every page shows four profiles for both replicates in HeLa and HEK293 cells. Blue and red lines 
show median profiles of 40S and 60S core RPs. Orange lines show the profile of the individual 
polysome interactor. If an individual protein is considered to be a polysome interactor in a given 
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experiment its identifier and MSD value is depicted. Histograms show the distribution of MSD 
values with the position of the respective protein indicated by an arrow (see Figure 2C). The 
scatter plots depicts MSD values separately for 40S and 60S fractions to assess subunit-
specific binding (see also Figure 2J and S2C). Class I and II category include proteins which 
passed a MSD cut-off in both biological replicates and proteins which only passed a cut-off in 
one of the two replicates in either cell line, respectively. 
❡ 
Supplemental table titles 
Table S1: A list of proteins and their MSD (mean squared deviation) values; related to Figure 2¶ 
Table S2: A reference for known ribosome-related proteins; related to Figure 2G¶ 
Table S3: pSILAC data for HEK293; related to Figure 5A¶ 
Table S4: RNA-seq data for HEK293; related Figure 5B¶ 
Table S5: pSILAC data for mouse B cells; related to Figure 6B¶ 
Table S6: Ribosome profiling data for mouse B cells; related to Figure 6D¶ 
❡ 
SUPPLEMENTAL INFORMATION ¶ 




- High resolution polysome proteome profiling across ribosomal subcomplexes 
- Core ribosome of monosomes and polysomes does not differ significantly 
- 145 proteins associate with actively translating polysomes 
- Phosphorylation of RPL12/uL11 regulates translation during mitosis. 
 
eTOC blurb 
Multiple regulatory layers shape gene expression. Imami et al. show that protein production in 
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RPS6/eS6: S235, 236, 240 (triple)
RLSSLRASTSKSESSQK


































rep1 (L) rep2 (H)
IS (M)













































































































P1 (T22, S58, S101, S104)



























































































- Flag (tagged RPL12/uL11)
- AHA (newly synthesized protein)
- Histone H3 pS10 (mitotic marker) 
RPL12/uL11 pS38 (Olsen et al)
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HEK293 stable cell lines 
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mito/AS>1.4 (this study), p=1.5e−3
mito/AS<0.7 (this study), p=1.0e−4
mito/S>2 (Stumpf et al), p=2.6e−5






























































mito/AS>1.4 (this study), p=1.9e−55
mito/AS<0.7 (this study), p=2.5e−57
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Waldorf_20161219_KI_MM_270_whole_A11-WT #44535 RT: 114.88 AV: 1 NL: 1.67E8
T: FTMS + p NSI Full ms [300.0000-1700.0000]




























441.24 445.12441.78440.72 442.28 443.75443.22
waldorf_20161219_ki_mm_270_whole_d2b2-wt #44341 RT: 112.63 AV: 1 NL: 4.15E8
T: FTMS + p NSI Full ms [300.0000-1700.0000]






























waldorf_20161219_ki_mm_270_whole_wt-wt #44395 RT: 113.59 AV: 1 NL: 2.55E8
T: FTMS + p NSI Full ms [300.0000-1700.0000]




































waldorf_20161219_ki_mm_270_whole_wt-wt #42646 RT: 110.32 AV: 1 NL: 5.91E7
T: FTMS + p NSI Full ms [300.0000-1700.0000]
































waldorf_20161219_ki_mm_270_whole_d2b2-wt #42715 RT: 109.60 AV: 1 NL: 4.14E7
T: FTMS + p NSI Full ms [300.0000-1700.0000]
































Waldorf_20161219_KI_MM_270_whole_A11-WT #42616 RT: 111.27 AV: 1 NL: 7.10E7
T: FTMS + p NSI Full ms [300.0000-1700.0000]



































Waldorf_20161219_KI_MM_270_whole_A11-WT #46832 RT: 119.18 AV: 1 NL: 4.40E8
T: FTMS + p NSI Full ms [300.0000-1700.0000]


























434.78 437.23 437.56435.28 438.26432.77 436.88 438.76435.79
waldorf_20161219_ki_mm_270_whole_d2b2-wt #47916 RT: 119.38 AV: 1 NL: 6.65E8
T: FTMS + p NSI Full ms [300.0000-1700.0000]
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Light mouse B cells 





































































mito/AS>1.4 (this study), p=1.2e−3
mito/AS<0.7 (this study), p=2.9e−7
mito/S>2 (Stumpf et al), p=6.5e−5
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